Vanda Pharmaceuticals Inc. (VNDA) Social Stream
VANDA PHARMACEUTICALS INC (VNDA) Price Targets From Analysts
Use the tables below to see what analysts covering VANDA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 2 | $24 | $22 | $23 | $4.22 | 445.02% |
| 2021-11-23 | 3 | $24 | $24 | $24 | $4.22 | 468.72% |
| 2022-02-04 | 2 | $24 | $20 | $22 | $4.22 | 421.33% |
| 2022-02-25 | 2 | $16 | $12 | $14 | $4.22 | 231.75% |
| 2022-04-24 | 1 | $12 | $12 | $12 | $4.22 | 184.36% |
| 2022-08-03 | 1 | $10 | $10 | $10 | $4.22 | 136.97% |
| 2022-11-03 | 1 | $11 | $11 | $11 | $4.22 | 160.66% |
| 2023-05-10 | 1 | $7.001 | $7.001 | $7.001 | $4.22 | 65.9% |
| 2023-07-27 | 1 | $7 | $7 | $7 | $4.22 | 65.88% |
| 2023-10-11 | 1 | $5.4 | $5.4 | $5.4 | $4.22 | 27.96% |
| 2023-11-09 | 1 | $4.25 | $4.25 | $4.25 | $4.22 | 0.71% |
The Trend in the Analyst Price Target
VNDA's average price target has moved down $18.75 over the prior 28 months.
VNDA reports an average of 10.45% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-03 | 1 | 7.000 | 7.000 | 7.000 | 6.39 | 9.55% |
| 2023-05-10 | 1 | 7.001 | 7.001 | 7.001 | 6.78 | 3.26% |
| 2023-07-27 | 1 | 7.000 | 7.000 | 7.000 | 6.46 | 8.36% |
| 2023-10-11 | 1 | 5.400 | 5.400 | 5.400 | 4.52 | 19.47% |
| 2023-11-09 | 1 | 4.250 | 4.250 | 4.250 | 3.38 | 25.74% |
VNDA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 20 months, VNDA's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, VANDA PHARMACEUTICALS INC's number of analysts covering the stock is higher than 28.91% of them.
- In the context of Pharmaceutical Products stocks, VANDA PHARMACEUTICALS INC's variance in analysts' estimates is lower than 1.05% of them.
- In the context of Healthcare stocks, VANDA PHARMACEUTICALS INC's average analyst price target is greater than 372.01% of them.
- VNDA has a higher upside potential (average analyst target price relative to current price) than 970.3% of stocks in the small market cap category.
Stocks similar to VANDA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OMER, MACK, and ALIM.
View All Top Stocks by Price Target
Is VNDA a Buy, Hold or Sell? See the POWR Ratings now!